ATE84066T1 - Elektrolytloesungen und deren in-vitro-verwendung. - Google Patents

Elektrolytloesungen und deren in-vitro-verwendung.

Info

Publication number: ATE84066T1
Authority: AT; Austria
Prior art keywords: vitro use; media; electrolyte solutions; intracellular; betahydroxybutyrate
Prior art date: 1984-06-22

Application number

AT85903546T

Other languages

English (en)

Inventor

Richard L Veech

Original Assignee

Richard L Veech

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-06-22

Filing date

1985-06-24

Publication date

1993-01-15

1985-06-24 Application filed by Richard L Veech filed Critical Richard L Veech

1993-01-15 Application granted granted Critical

1993-01-15 Publication of ATE84066T1 publication Critical patent/ATE84066T1/de

Links

238000000338 in vitro Methods 0.000 title abstract 2
239000008151 electrolyte solution Substances 0.000 title 1
229940021013 electrolyte solution Drugs 0.000 title 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 2
230000003834 intracellular effect Effects 0.000 abstract 2
-1 sodium cations Chemical class 0.000 abstract 2
WHBMMWSBFZVSSR-GSVOUGTGSA-M (R)-3-hydroxybutyrate Chemical compound C[C@@H](O)CC([O-])=O WHBMMWSBFZVSSR-GSVOUGTGSA-M 0.000 abstract 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 abstract 1
JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 abstract 1
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 abstract 1
WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 abstract 1
239000003855 balanced salt solution Substances 0.000 abstract 1
229910002092 carbon dioxide Inorganic materials 0.000 abstract 1
239000001569 carbon dioxide Substances 0.000 abstract 1
238000011534 incubation Methods 0.000 abstract 1
229940116871 l-lactate Drugs 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
238000010606 normalization Methods 0.000 abstract 1
230000010412 perfusion Effects 0.000 abstract 1
230000026731 phosphorylation Effects 0.000 abstract 1
238000006366 phosphorylation reaction Methods 0.000 abstract 1
229910052708 sodium Inorganic materials 0.000 abstract 1
239000011734 sodium Substances 0.000 abstract 1
239000003104 tissue culture media Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Cell Biology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT85903546T 1984-06-22 1985-06-24 Elektrolytloesungen und deren in-vitro-verwendung. ATE84066T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US62310284A	1984-06-22	1984-06-22
PCT/US1985/001203 WO1986000335A1 (en)	1984-06-22	1985-06-24	Electrolyte solutions and in vitro use thereof
EP85903546A EP0188529B1 (de)	1984-06-22	1985-06-24	Elektrolytlösungen und deren in-vitro-verwendung

Publications (1)

Publication Number	Publication Date
ATE84066T1 true ATE84066T1 (de)	1993-01-15

Family

ID=24496782

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT85903546T ATE84066T1 (de)	1984-06-22	1985-06-24	Elektrolytloesungen und deren in-vitro-verwendung.

Country Status (7)

Country	Link
EP (1)	EP0188529B1 (de)
JP (1)	JPS61502933A (de)
AT (1)	ATE84066T1 (de)
AU (1)	AU4540285A (de)
CA (1)	CA1280082C (de)
DE (1)	DE3586946D1 (de)
WO (1)	WO1986000335A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE38604E1 (en)	1984-06-22	2004-09-28	Btg International Limited	Fluid therapy with L-lactate and/or pyruvate anions
US4668400A (en) *	1984-06-22	1987-05-26	Veech Richard L	Hemodialysis processes and hemodialysis solutions
CA1249970A (en) *	1984-06-22	1989-02-14	Richard L. Veech	Electrolyte solutions containing polyanionic materials
ATE82500T1 (de) *	1984-06-22	1992-12-15	Richard L Veech	Elektrolytloesungen und deren (in vivo) verwendung.
EP0230430A4 (de) *	1985-06-12	1989-03-09	Luminis Pty Ltd	Kulturmedium für in-vitro-befruchtung und embryo-übertragung.
JPH0733601A (ja) *	1992-04-01	1995-02-03	Ho Chen Chun	組織保存用組成物
US5719050A (en) *	1993-12-24	1998-02-17	Eiken Chemical Co., Ltd.	Animal cell culturing media containing N-acetyl-L-glutamic acid
IL151169A0 (en) *	2002-08-09	2003-04-10	Talgon Invest Ltd	A peritoneal dialysis solution

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US30985A (en) *		1860-12-18		Thomas l
US3122476A (en) *	1960-06-21	1964-02-25	Hyland Lab	Tissue culture medium
US3821368A (en) *	1971-06-01	1974-06-28	Cybersal Inc	Therapeutic composition
US3993751A (en) *	1972-11-27	1976-11-23	Cybersol, Inc.	Process for stabilizing therapeutic compositions and article
CA1017249A (en) *	1973-12-19	1977-09-13	Chemo Drug Company	Injectable electrolyte solutions
DE2532183C3 (de) *	1975-07-18	1982-03-04	Behringwerke Ag, 3550 Marburg	Polyionische isotonische Salzlösung zur Konservierung von Erythrozyten oder zur Perfusion und zur Konservierung von zur Transplantion bestimmter Organen
US4186253A (en) *	1978-10-10	1980-01-29	The Green Cross Corporation	Perfusate for preserving organ to be transplanted and preserving method
US4282326A (en) *	1978-10-12	1981-08-04	Jeanne Moldenhauer	Cell culture medium supplement
JPS5632411A (en) *	1979-08-27	1981-04-01	Tomita Seiyaku Kk	Preparation of perfusion liquid for artificial kidney dialysis
US4308255A (en) *	1980-03-24	1981-12-29	Haemophor Corporation	Balanced oncotic pressure fluid
US4443546A (en) *	1980-07-07	1984-04-17	The Beth Israel Hospital Association	Process and composition for propagating mammalian cells
US4489535A (en) *	1980-10-02	1984-12-25	Veltman Preston Leonard	Materials and method for preparing dialysis solutions containing bicarbonate ions
US4473647A (en) *	1981-02-27	1984-09-25	Amf Inc.	Tissue culture medium
US4443432A (en) *	1981-10-05	1984-04-17	Alcon Laboratories, Inc.	Ophthmalic irrigating solution
CA1216518A (en) *	1982-11-01	1987-01-13	Gail A. Rock	Plasma-free medium for platelet storage

1985
- 1985-06-24 DE DE8585903546T patent/DE3586946D1/de not_active Expired - Lifetime
- 1985-06-24 AT AT85903546T patent/ATE84066T1/de not_active IP Right Cessation
- 1985-06-24 JP JP60502894A patent/JPS61502933A/ja active Pending
- 1985-06-24 WO PCT/US1985/001203 patent/WO1986000335A1/en not_active Ceased
- 1985-06-24 CA CA000484983A patent/CA1280082C/en not_active Expired - Lifetime
- 1985-06-24 EP EP85903546A patent/EP0188529B1/de not_active Expired
- 1985-06-24 AU AU45402/85A patent/AU4540285A/en not_active Abandoned

Also Published As

Publication number	Publication date
JPS61502933A (ja)	1986-12-18
EP0188529A4 (de)	1988-12-01
AU4540285A (en)	1986-01-24
DE3586946D1 (de)	1993-02-11
WO1986000335A1 (en)	1986-01-16
CA1280082C (en)	1991-02-12
EP0188529A1 (de)	1986-07-30
EP0188529B1 (de)	1992-12-30

Similar Documents

Publication	Publication Date	Title
ATE82500T1 (de)	1992-12-15	Elektrolytloesungen und deren (in vivo) verwendung.
AU4177585A (en)	1985-11-14	Pyridazinones,preparation process thereof and utilization thereof, drugs containing pyridazinones
WO1987002662A3 (en)	1987-12-17	Heterocyclic analogs of mevalonolactone and derivatives thereof, processes for their production and their use as pharmaceuticals
CA2382569A1 (en)	2001-03-01	Super-oxidized water, preparation and use therefor as sterilizers and medicaments
ATE294597T1 (de)	2005-05-15	Lösung für die peritonealdialyse
ATE84066T1 (de)	1993-01-15	Elektrolytloesungen und deren in-vitro-verwendung.
ES8602939A1 (es)	1985-12-16	Un procedimiento para producir sales estables de sulfo-ade- nosil-l-metionina
AU5357179A (en)	1980-06-12	4-amino-2-ureido-pyrimidine-5-carboxylic acid anilides and their use in treating lipometabolism disturbances and adiposity
AU4500085A (en)	1986-01-24	Electrolyte solutions containing polyanionic materials
MY113803A (en)	2002-05-31	Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as medicament or diagnostic, and medicament containing them.
FR2559499B1 (fr)	1986-09-19	Nouveau milieu de culture, solide, a delitement rapide, pret a l'emploi et procede pour le preparer
Forte et al.	1964	Relation between hydrogen ion secretion and oxygen uptake by gastric mucosa
GB9118664D0 (en)	1991-10-16	Cell culture
Halme et al.	1969	Effect of tetracycline on collagen biosynthesis in cultured embryonic bones
Bisaillon et al.	1975	Growth of calcium oxalate in gel systems
GB1491816A (en)	1977-11-16	Urokinase production
FR2332341A1 (fr)	1977-06-17	Traitement electrolytique avec des membranes echangeuses d'ions
DK251284A (da)	1984-11-24	Substituerede 1,2,3-triazino(4',5'.4,5)thieno(2,3-b)-quinolin-4(3h)-oner eller syreadditionssalte deraf og deres fremstilling
ES8500908A1 (es)	1984-11-01	Procedimiento para la obtencion de hidantoinas n-sulfeniladas
ES8104188A1 (es)	1981-04-16	Un procedimiento para la preparacion de nuevas 3-fenilpropi-laminas n-sustituidas
SU1259134A1 (ru)	1986-09-23	Среда дл инкубации митохондрий
AU568701B2 (en)	1988-01-07	Indane derivatives of methanesulfonamide
SAITO et al.	1970	Effect of lithium substitution for sodium on oxygen consumption of guinea pig taenia coli in high K medium
Davies	1967	The metabolism of gastric mucosa during the secretion of hydrochloric acid
AU575707B2 (en)	1988-08-04	Controlling conditions in electrolysis of sulfate containing brine

Legal Events

Date	Code	Title	Description
1993-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties